Blog Archives
Matt Kaeberlein on which longevity supplements might really work, and which don’t
Professor Matt Kaeberlein is an outspoken proponent of rapamycin, and pretty skeptical about virtually all the other interventions people talk most about. Here he lays out a pretty complete and persuasive model for why and how aging happens at all,
Matt Kaeberlein on which longevity supplements might really work, and which don’t
Professor Matt Kaeberlein is an outspoken proponent of rapamycin, and pretty skeptical about virtually all the other interventions people talk most about. Here he lays out a pretty complete and persuasive model for why and how aging happens at all,
Nir Barzilai on the genes of centenarians and some nuance on metformin
A rare MD at the cutting edge of the longevity field, Dr. Barzilai heads the Institute for Longevity Research at Einstein. We cover his unique contributions, especially the currently buzzy topic of metformin, as well as his work on the
Nir Barzilai on the genes of centenarians and some nuance on metformin
A rare MD at the cutting edge of the longevity field, Dr. Barzilai heads the Institute for Longevity Research at Einstein. We cover his unique contributions, especially the currently buzzy topic of metformin, as well as his work on the
Jean Herbert on regenerating the brain in the lab
One of the more incredible research programs in longevity is regeneration: rebuilding and replacing failing organs with lab-grown cells. Jean Herbert at Einstein is working on regenerating your brain.
Jean Herbert on regenerating the brain in the lab
One of the more incredible research programs in longevity is regeneration: rebuilding and replacing failing organs with lab-grown cells. Jean Herbert at Einstein is working on regenerating your brain.
James Peyer from Cambrian Biosciences and Apollo Health Ventures tells us how to play longevity to win
This founder has been part of so many of the exciting longevity startups, investments, and discussions that you simply must understand the world the way he sees it before taking a view about life extension. In this episode, you will.
James Peyer from Cambrian Biosciences and Apollo Health Ventures tells us how to play longevity to win
This founder has been part of so many of the exciting longevity startups, investments, and discussions that you simply must understand the world the way he sees it before taking a view about life extension. In this episode, you will.
Aubrey de Grey, the longevity OG, gives us a peek into the early days of the cult of living forever
Longevity superstar alert. A deep dive with one of the most recognized and longest-serving visionaries of longevity world. After recording this episode, friends pointed out that I didn’t cover big important parts of personal history that are covered here: https://en.wikipedia.org/wiki/Aubrey_de_Grey
Aubrey de Grey, the longevity OG, gives us a peek into the early days of the cult of living forever
Longevity superstar alert. A deep dive with one of the most recognized and longest-serving visionaries of longevity world. After recording this episode, friends pointed out that I didn’t cover big important parts of personal history that are covered here: https://en.wikipedia.org/wiki/Aubrey_de_Grey
Vincere Bio’s computer model for solving Parkinson’s with the cofounders Spring Behrouz and Andy Lee
The easy way to attack Parkinson’s? A neuron-by-neuron model of the brain.
Vincere Bio’s computer model for solving Parkinson’s with the cofounders Spring Behrouz and Andy Lee
The easy way to attack Parkinson’s? A neuron-by-neuron model of the brain.
Altos Labs’ Morgan Levine on how to measure biological age and why she left Yale
Cellular rejuvenation is in the house on this episode, and fundamental research on the processes far beneath the surface of your typical aging research. And a little peek into the billionaire-backed mega-project happening at Altos.
Altos Labs’ Morgan Levine on how to measure biological age and why she left Yale
Cellular rejuvenation is in the house on this episode, and fundamental research on the processes far beneath the surface of your typical aging research. And a little peek into the billionaire-backed mega-project happening at Altos.
You must be logged in to post a comment.